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In constructed wetlands micropollutants can be removed from water by phytoremediation. However,
micropollutant uptake andmetabolismbyplants here is poorly understood due to the lack of good analytical
approaches. Reported herein is the ﬁrst methodology developed and validated for the multi-residue
determination of 81 micropollutants (pharmaceuticals, personal care products and illicit drugs) in the
emergent macrophyte Phragmites australis. The method involved extraction by microwave accelerated
extraction (MAE), clean-up using off-line solid phase extraction and analysis by ultra-high-performance
liquid chromatography tandem mass spectrometry. Development of the MAE method found the inﬂuence
of studied variables on micropollutant recovery to be: extraction temperature > sample mass > solvent
composition. Validation of the developed extraction protocol revealedmethod recoveries were in the range
80e120% for the majority of micropollutants. Method quantitation limits (MQLs) were generally <5 ng g1
dryweight demonstrating the sensitivity of themethodology. Application of themethod toP. australis froma
constructed wetland used to treat trickling ﬁlter efﬂuent found 17 micropollutants above their MQL, up to
concentrations of 200 ng g1. Other than uptake, the presence of several metabolites (carbamazepine 10,11
epoxide, desvenlafaxine, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, N-desmethyltramadol and
norketamine) indicated metabolismwithin the plant may also occur. This new analytical methodology will
enable a process mass balance of the constructed wetland to be attained for the ﬁrst time, and thus help
understand the role of phytoremediation in micropollutant removal by such systems.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).University of Bath, Bath, BA2 7AY, UK.
. Kasprzyk-Hordern).
ences, Robert Gordon University, Aberdeen AB10 7JG, UK.
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Organic micropollutants such as pharmaceuticals, personal care
products and illicit drugs are ubiquitous in surface waters at the
low ng L1 to mg L1 concentration range [1,2]. This is of concern as
they can exert adverse toxicological responses to aquatic biota [3].
The presence of these micropollutants in the aquatic environment
is mainly attributed to their incomplete removal during conven-
tional wastewater treatment [2]. Currently, low-cost tertiary
treatment options such as constructed wetlands are being consid-
ered for efﬂuent polishing. Their primary use is to enhance the
removal of macropollutants such as suspended solids, organic
matter and nutrients. However, fortuitous removal of micro-
pollutants such as pharmaceuticals is also observed [4].
Constructed wetlands tend to be surface ﬂow (water ﬂows over
a benthic substrate) or sub-surface ﬂow (water ﬂows through a
porous medium such as gravel) [4]. These systems utilize macro-
phytes (such as Phragmites australis e the common reed) which are
thought to contribute to the removal of micropollutants during
treatment [5]. Several studies have investigated the removal of
micropollutants by constructed wetlands [6e10]. This has involved
comparing micropollutant concentrations or loads in receiving
water and treated water. On the other hand, laboratories studies
have been conducted using macrophytes and a synthetic water
medium containing micropollutants of interest [11e13]. Such
studies tend to rely on measuring the reduction in micropollutant
concentration in the water medium to quantify uptake. However,
little analysis has been conducted directly on plants grown in
constructed wetlands treating real wastewater. This is due to the
lack of good analytical approaches for the determination of
micropollutants in plant matter found in constructed wetlands. To
date, there are no fully validated methods reported in the literature
speciﬁcally developed for the determination of micropollutants in
plants found in constructed wetlands.
Numerous methods have previously been developed and vali-
dated for the determination of micropollutants in other plant types
such as vegetables and cereals [14e18]. In such matrices, method
quantitation limits (MQLs) range from <1 to ~1000 ng g1. Some
studies have applied these methods to determine a limited number
of micropollutants in plants from constructed wetlands. Zarate
et al. [19] investigated the personal care products triclosan, meth-
yltriclosan and triclocarban in three constructed wetland macro-
phytes: Typha latifolia, Pontederia cordata and Sagittaria graminea.
Both triclosan and triclocarbanwere ubiquitous in the studied plant
tissues atmean concentrations up to ~50 ng g1 [19]. Hijosa-Valsero
et al. [20] investigated several pharmaceuticals and personal care
products (naproxen, ibuprofen, ketoprofen, salicylic acid, caffeine,
diclofenac, carbamazepine, galaxolide, methyldihydrojasmonate
and tonalide) in the roots of P. australis with concentrations up to
2500 ng g1 found. The most commonly applied extraction
methods for organic micropollutants from solid environmental
matrices are ultra-sonic extraction (USE), microwave accelerated
extraction (MAE) and pressurised liquid extraction (PLE) [20e23].
Dorival-Garcia et al. [21] found little difference in extraction efﬁ-
ciency of quinolone antibiotics from sewage sludge using USE, MAE
and PLE. However, both MAE and PLE enable greater automation
compared to USE [21]. Furthermore, MAE can provide further time
savings as several samples can be extracted simultaneously.
Due to the lack of methods reported in the literature for the
determination of micropollutants in plants grown in constructed
wetlands, the aim of this study was to develop a robust and sen-
sitive method for the extraction of a high number of micro-
pollutants in P. australis. This is the ﬁrst time a method has been
developed and validated speciﬁcally for the determination of
micropollutants in this matrix. A total of 81 micropollutants wereinvestigated to encompass a range of physico-chemical and bio-
logical properties (Table S1). This was achieved by developing a
newMAEmethod, and utilising off-line solid phase extraction (SPE)
and ultra-high-performance liquid chromatography tandem mass
spectrometry (UHPLC-MS/MS).
2. Materials and methods
2.1. Materials
A total of 81 micropollutants representing a varied range of
physico-chemical andbiological propertieswere investigated during
the study (Table S1). The labelled internal standards acetaminophen-
D4, ibuprofen-D3, bisphenol A-D16, carbamazepine-13C6, ketopro-
fen-D3, naproxen-D3, propranolol-D7 and atenolol-D5 were pur-
chased from Sigma-Aldrich (Gillingham, UK). Bezaﬁbrate-D6 was
obtained fromQMX laboratories (Thaxted, UK). Methylparaben-13C,
amphetamine-D5, methamphetamine-D5, 3,4-methylenedioxy-
methamphetamine-D5 (MDMA-D5), 3,4-methylenedioxy-amphet-
amine-D5 (MDA-D5), heroin-D9, codeine-D6, ketamine-D4,
cocaine-D3, benzoylecgonine-D8, 2-ethylidene-1,5-dimethyl-3,3-
diphenylpyrrolidine-D3 (EDDP-D3), morphine-D3, cotinine-D3,
cocaethylene-D8, temazepam-D5, 1S,2R-(þ) ephedrine-D3, mephe-
drone-D3, methadone-D9, norketamine-D4, estrone (2,4,16,16-D4),
estradiol (2,4,16,16-D4) and quetiapine-D8 hemifumurate were
purchased from LGC standards (Middlesex, UK). Citalopram-D6,
metoprolol-D7, and mirtazapine-D3 were obtained from TRC (Tor-
onto, Canada). All standards were purchased as 0.1 or 1.0 mg mL1
solutions or in powder form. Chemicals in powder form were pre-
pared at a concentration of 1 mg mL1 in the recommended solvent
and stored at 20 C. Stock solutions of antibiotics were prepared
monthly [23].
Methanol (MeOH) and toluene was HPLC grade and purchased
from Sigma-Aldrich. Water (H2O) was of 18.2 MU quality (Elga,
Marlow, UK). All glassware was deactivated using 5% dimethyl-
chlorosilane (DMDCS) in toluene (SigmaeAldrich) to mitigate the
loss of basic chemicals onto -OH sites present on glass surfaces. This
consisted of rinsing once with DMDCS, twice with toluene and
three times withMeOH. Ammonium acetate (NH4OAc), ammonium
ﬂuoride (NH4F) and acetic acid (1.0 M, CH3COOH) used for the
preparation of mobile phases were purchased from Sigma-Aldrich.
Oasis HLB (60 mg, 3 mL) SPE cartridges were purchased from
Waters (Manchester, UK).
2.2. Constructed wetlands
P. australis were collected from a constructed wetland in the
South-West of the UK. The wastewater treatment plant itself con-
sists of primary sedimentation, secondary treatment by trickling
ﬁlters and sedimentation followed by constructed wetlands as a
ﬁnal polishing step. The site serves a population equivalent of
12,500. The constructed wetlands consisted of six different beds, all
being non-aerated horizontal sub-surface ﬂow with differing sub-
strates planted with P. australis. The depth of substrate was
approximately 1 m in each bed resulting in a hydraulic retention
time of approximately 14 h under dry weather conditions.
P. australis were collected on four consecutive days near both the
inlet and outlet of the bed containing gravel as the substrate. This
bed was considered well-established as P. australis had been
growing for one year and were generally 1.5e2.0 m in height.
P. australis were transported to the laboratory on ice, and roots
washed with tap water to remove excess sediment. These were
then frozen immediately at 20 C prior to further processing. It is
assumed that freezing reeds upon collection inhibits the degrada-
tion of target micropollutants until analysis.
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Once frozen, individual plants were freeze dried (ScanVac,
CoolSafe freeze dryer, Lynge, Denmark). These were then homog-
enized using a mechanical blender (Kenwood, Havant, UK).
Representative 0.5 g samples were spiked with 50 ng of all internal
standards (in 50 mLMeOH) and left for aminimum of 2 h. Extraction
was performed using 25 mL of 25:75 MeOH:H2O at a temperature
of 50 C using a 800 W MARS 6 microwave (CEM, UK). Samples
were heated to 50 C over 10 min and maintained at this temper-
ature for 30 min. Once cooled samples were ﬁltered through glass
ﬁbre membranes (0.7 mm) and diluted with H2O to achieve a ﬁnal
MeOH concentration of <5%, ready for SPE.
During the development process, extraction temperatures of 30,
50, 70, 90, 110 and 130 C were tested. Extraction solvent compo-
sitions of 25:75, 50:50 and 75:25 MeOH:H2O and sample masses of
0.5, 1.0 and 2.0 g were also investigated. When trialling different
extraction solvent compositions, all samples were diluted to
500 mL using H2O to avoid varying amounts of MeOH in the extract
having any inﬂuence on SPE recovery. To validate the method and
determine recoveries, samples were spiked at concentration levels
of 25, 50 and 125 ng g1. All analysis was performed in triplicate.
2.4. Solid phase extraction
An existing SPE protocol was applied as it was known to be
successful for the simultaneous extraction of all micropollutants
investigated here [23]. Oasis HLB cartridges were conditioned using
2 mL MeOH followed by 2 mL H2O at a ﬂow rate of 1 mL min1.
Samples were then loaded at a constant ﬂow rate of 5 mL min1
and dried under vacuum. Analytes were then eluted using 4 mL
MeOH at a ﬂow rate of 1 mLmin1. These extracts were dried under
nitrogen at 40 C using a TurboVap evaporator (Caliper, UK, <5 psi).Fig. 1. Overview of developed analytical protocol usedDried extracts were reconstituted in 500 mL 80:20H2O:MeOH,
ﬁltered through pre-LC-MS 0.2 mm PTFE ﬁlters (Whatman, Pur-
adisc) and transferred to polypropylene vials (Waters, Manchester,
UK) ready for UHPLC-MS/MS analysis.
2.5. Ultra-high-performance liquid chromatography tandem mass
spectrometry
Two chromatography methods were used to ensure maximum
sensitivity was achieved for the varied range of micropollutants
studied [23]. Acidic micropollutants were separated using a
gradient of 1 mM NH4F in 80:20H2O:MeOH (mobile phase A) and
1 mM NH4F in 5:95H2O:MeOH (mobile phase B). Initial conditions
of 100% Awere maintained for 0.5 min before reducing to 40% over
2 min and further reduced to 0% over 5.5 min. This was maintained
for 6 min before returning to starting conditions which were
maintained for 8.4 min to re-equilibrate the column.
For basic micropollutants, separation was achieved using 5 mM
NH4OAc and 3 mM CH3COOH in 80:20H2O:MeOH (mobile phase A)
and MeOH (mobile phase B). Starting conditions of 100% A were
reduced to 10% over 20 min and maintained for a further 6 min.
Following this, mobile phase conditions were returned to starting
conditions and held for 7.5 min for re-equilibration. Both methods
utilised a reversed-phase BEH C18 column (150  1.0 mm, 1.7 mm
particle size) (Waters, Manchester, UK) ﬁtted with a 0.2 mm, 2.1 mm
in-line preﬁlter to remove particulates using aWaters Acquity UPLC
system (Waters, Manchester, UK). The column was maintained at
40 C and the mobile phase ﬂow rate was 0.04 mL min1. The in-
jection volume for both methods was 15 mL.
The UPLC systemwas coupled to a Xevo TQD Triple Quadrupole
Mass Spectrometer (Waters, Manchester, UK), equipped with an
electrospray ionisation (ESI) source. Acidic micropollutants were
analysed in negative ionisationmode (ESI -) with a capillary voltageto determine target micropollutants in P. australis.
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isation mode (ESI þ) with a capillary voltage of 3.00 kV. The opti-
mised MS/MS transitions can be found in Table S2. In both methods
the source temperature was 150 C whilst the desolvation tem-
perature was 400 C. A cone gas ﬂow of 100 L h1and a desolvation
gas ﬂow of 550 L h1 was used. Finally, the nebulising and des-
olvation gases were nitrogen, and the collision gas was argon. An
overview of the entire analytical protocol is detailed in Fig. 1.3. Results and discussion
3.1. Ultra-high-performance liquid chromatography tandem mass
spectrometry
The UHPLC-MS/MSmethod applied in this study was previously
developed and optimised for the studied micropollutants as
described in Petrie at al [23]. Brieﬂy, instrument detection limits
(IDLs) ranged from 0.01 to 1.16 ng mL1 and instrument quantita-
tion limits (IQLs) from 0.04 to 5.79 ng mL1 (Table 1). A 17 level
calibration curve was prepared with the majority ofTable 1
Instrument detail of studied micropollutants including instrument detection and quanti
Micropollutant class Micropollutant Rt
(min)
ESI
mode
Corre
stand
UV ﬁlters Benzophenone-1 9.6 e Bisph
Benzophenone-2 7.9 e Bisph
Benzophenone-3 21.2 þ Meth
Benzophenone-4 6.9 e Meth
Parabens Methylparaben 7.5 e Meth
Ethylparaben 8.3 e Napr
Propylparaben 9.2 e Napr
Butylparaben 10.1 e Napr
Plasticizer Bisphenol-A 9.0 e Bisph
Steroid estrogens E1 9.8 e E1-D
E2 9.7 e E2-D
EE2 9.8 e E2-D
Antibacterials/antibiotics Sulfasalazine 7.1 e Napr
Clarithromycin 18.9 þ Meth
Azithromycin 14.0 þ EDDP
Trimethoprim 8.4 þ Meth
Sulfamethoxazole 9.6 þ Benz
Hypertension Valsartan 7.6 e Napr
Irbesartan 8.6 e Bisph
NSAIDs Ketoprofen 7.7 e Ketop
Ibuprofen 9.8 e Ibupr
Naproxen 8.1 e Napr
Diclofenac 9.0 e Napr
Acetaminophen 5.1 þ Aceta
Lipid regulators Bezaﬁbrate 7.9 e Bezaﬁ
Atorvastatin 9.3 e Napr
Diabetes Gliclazide 17.8 þ CBZ-
Antihistamines Fexofenadine 8.4 e Bisph
Cetirizine 18.7 þ Tema
Cough suppressant Pholcodine 3.7 þ Aten
Beta-blocker Atenolol 4.3 þ Aten
Metoprolol 11.2 þ Meto
Propranolol 15.1 þ Propr
H2 receptor agonists Ranitidine 4.6 þ Cotin
Cimetidine 5.3 þ Code
X-ray contrast media Iopromide 4.9 þ Aten
Drug precursor and metabolite Ephedrine/pseudoephedrine 7.2 þ 1S,2R
Norephedrinea 6.3 þ 1S,2R
Anti-cancer Azathioprine 7.8 þ Cotin
Methotrexate 7.9 þ Amp
Ifosfamide 12.7 þ Meto
Anaesthetic and metabolite Ketamine 10.6 þ Ketam
Norketaminea 11.1 þ Nork
Anti-depressants and
metabolites
Venlafaxine 14.1 þ Meto
Desmethylvenlafaxinea 10.8 þ Metomicropollutants exhibiting linearity between the IQL and
500 ng mL1 with r2 of 0.997 (Table 1). Most micropollutants
demonstrated intra- and inter-day precision of <10% (Table S3).
Accuracy generally ranged from 90 to 110% both within the same
day and between different days (Table S4). For further discussion on
the instrument validation please refer to Petrie et al. [23]. To ensure
quality of data, standard tolerances of ion ratio and chromato-
graphic retention time were employed throughout the study [24].3.2. Microwave assisted extraction method development
From previous experience and a review of the literature
[21e23], three extraction parameters were considered to have the
greatest impact on analyte recovery using MAE: (i) extraction
temperature, (ii) extraction solvent composition, and (iii) sample
mass. Therefore these were the focus of investigation during the
development process.
Previously developed MAE methods for the extraction of
micropollutants from solid environmental matrices (wastewater
sludge, sediments and soils) have used extraction temperaturestation limits (n ¼ 81, ordered by micropollutant class).
sponding internal
ardb
Linearity IDLS/N
(ng mL1)
IQLS/N
(ng mL1)
Range
(ng mL1)
r2
enol A-D16 0.06e500 0.995 0.01 0.06
enol A-D16 0.05e500 0.998 0.01 0.05
adone-D9 0.05e400 0.990 0.01 0.05
ylparaben-13C 1.01e500 0.993 0.31 1.01
ylparaben-13C 0.06e500 1.000 0.01 0.06
oxen-D3 0.11e500 0.997 0.03 0.11
oxen-D3 0.12e400 0.998 0.04 0.12
oxen-D3 0.06e500 0.999 0.01 0.06
enol A-D16 0.10e500 0.998 0.03 0.10
4 0.49e500 0.999 0.10 0.49
4 0.47e500 0.999 0.09 0.47
4 0.48e500 0.995 0.10 0.48
oxen-D3 0.90e500 0.996 0.27 0.90
adone-D9 0.06e500 1.000 0.01 0.06
-D3 0.11e500 0.999 0.03 0.11
amphetamine-D5 0.10e500 0.999 0.03 0.10
oylecgonine-D8 0.10e500 0.999 0.03 0.10
oxen-D3 1.12e500 0.993 0.34 1.12
enol A-D16 0.50e500 0.998 0.10 0.50
rofen-D3 0.54e500 0.998 0.11 0.54
ofen-D3 0.05e500 0.999 0.01 0.05
oxen-D3 0.49e500 0.998 0.10 0.49
oxen-D3 0.10e500 0.995 0.03 0.10
minophen-D4 0.54e500 0.999 0.11 0.54
brate-D6 0.10e500 1.000 0.03 0.10
oxen-D3 0.05e500 0.990 0.01 0.05
13C6 0.05e500 0.998 0.01 0.05
enol A-D16 0.09e500 0.998 0.03 0.09
zepam-D5 0.08e500 1.000 0.02 0.08
olol-D7 1.14e500 0.994 0.35 1.14
olol-D7 0.10e500 1.000 0.03 0.10
prolol-D7 0.05e500 0.999 0.01 0.05
anolol-D7 0.09e500 0.999 0.03 0.09
ine-D3 5.17e500 0.998 1.03 5.17
ine-D6 0.52e500 0.998 0.10 0.52
olol-D7 5.79e500 0.990 1.16 5.79
-(þ) Ephedrine-D3 0.10e500 1.000 0.03 0.10
-(þ) Ephedrine-D3 0.50e500 0.999 0.01 0.50
ine-D3 0.10e500 0.998 0.03 0.10
hetamine-D5 0.92e500 0.996 0.28 0.92
prolol-D7 0.05e500 0.999 0.01 0.05
ine-D4 0.05e500 0.999 0.01 0.05
etamine-D4 0.10e500 0.999 0.03 0.10
prolol-D7 0.04e500 1.000 0.01 0.04
prolol-D7 0.10e500 0.998 0.03 0.10
Table 1 (continued )
Micropollutant class Micropollutant Rt
(min)
ESI
mode
Corresponding internal
standardb
Linearity IDLS/N
(ng mL1)
IQLS/N
(ng mL1)
Range
(ng mL1)
r2
Mirtazapine 13.5 þ Mirtazapine-D3 0.05e500 0.999 0.01 0.05
Citalopram 15.1 þ Citalopram-D6 0.50e500 0.999 0.05 0.50
Desmethylcitaloprama 15.2 þ Citalopram-D6 0.05e500 0.999 0.01 0.05
Anti-epileptic and metabolites CBZ 16.2 þ CBZ-13C6 0.05e500 1.000 0.01 0.05
CBZ 10,11-epoxidea 13.5 þ CBZ-13C6 0.10e500 0.998 0.03 0.10
10,11-Dihydro-10-hydroxy
CBZa
13.5 þ CBZ-13C6 0.50e500 0.999 0.05 0.50
Human indicators Nicotine 3.3 þ Codeine-D6 1.00e500 0.996 0.30 1.00
Caffeine 8.3 þ Cotinine-D3 0.50e500 0.999 0.10 0.50
Cotininea 7.2 þ Cotinine-D3 0.05e500 0.999 0.01 0.05
Calcium channel blocker Diltiazem 16.7 þ CBZ-13C6 0.10e500 0.999 0.01 0.10
Hypnotic Temazepam 18.2 þ Temazepam-D5 0.05e500 0.999 0.01 0.05
Anti-psychotic Quetiapine 18.2 þ Quetiapine-D8 0.05e500 0.999 0.01 0.05
Veterinary Tylosin 17.6 þ Methadone-D9 0.56e500 0.997 0.11 0.56
Analgaesics and metabolites Morphine 3.5 þ Morphine-D3 1.00e500 0.997 0.30 1.00
Dihydromorphinea 3.3 þ Morphine-D3 0.05e500 0.998 0.01 0.05
Normorphinea 3.4 þ Morphine-D3 1.00e500 0.997 0.30 1.00
Methadone 17.6 þ Methadone-D9 0.05e400 0.998 0.01 0.05
EDDPa 14.8 þ EDDP-D3 0.05e500 0.999 0.01 0.05
Codeine 6.1 þ Codeine-D6 0.50e500 0.999 0.10 0.50
Norcodeinea 6.5 þ Codeine-D6 1.00e500 0.999 0.30 1.00
Dihydrocodeinea 5.5 þ Codeine-D6 0.10e500 0.999 0.03 0.10
Tramadol 11.0 þ Metoprolol-D7 1.00e500 0.999 0.01 1.00
N-desmethyltramadola 11.9 þ Cocaine-D3 0.50e500 0.999 0.01 0.50
O-desmethyltramadola 8.3 þ MDA-D5 1.00e400 0.997 0.01 1.00
Stimulants and metabolites Amphetamine 8.4 þ Amphetamine-D5 0.10e500 0.999 0.03 0.10
Methamphetamine 8.5 þ Methamphetamine-D5 0.10e500 0.999 0.03 0.10
MDMA 8.6 þ MDMA-D5 0.05e500 1.000 0.01 0.05
MDAa 8.6 þ MDA-D5 0.10e500 0.999 0.03 0.10
Cocaine 11.3 þ Cocaine-D3 0.05e500 1.000 0.01 0.05
Benzoylecgoninea 9.7 þ Benzoylecgonine-D8 0.05e500 0.998 0.01 0.05
AEMEa 3.5 þ Acetaminophen-D4 0.50e500 0.997 0.10 0.50
Cocaethylenea 12.9 þ Cocaethylene-D3 0.05e500 1.000 0.01 0.05
Mephedrone 9.8 þ Mephedrone-D3 0.05e500 0.998 0.01 0.05
MDPV 12.1 þ Cocaethylene-D3 0.05e500 0.999 0.01 0.05
Opioid and metabolite Heroin 10.9 þ Heroin-D9 0.50e500 0.999 0.10 0.50
6-acetylmorphinea 7.7 þ Cotinine-D3 0.10e500 0.998 0.03 0.10
Key: Rt, retention time; ESI, electro-spray ionisation; IDL, instrument detection limit; IQL, instrument quantitation limit; E1, estrone; E2, 17b-estradiol; EE2, 17a-ethiny-
lestradiol; CBZ, carbamazepine; EDDP, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine; MDMA, 3,4-methylenedioxy-methamphetamine; MDA, 3,4-methylenedioxy-
amphetamine; AEME, anhydroecgonine methylester; MDPV, methylenedioxypyrovalerone.
a Metabolite.
b Micropollutants without their own labelled internal standard are considered semi-quantitative [24].
B. Petrie et al. / Analytica Chimica Acta 959 (2017) 91e101 95ranging from 87 to 150 C, depending on the matrix and solvent
used for extraction [21,25]. In our study, extraction temperatures of
30, 50, 70, 90, 110 and 130 C were investigated. An extraction of
temperature of 50 C was found to give the highest recovery for the0
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Fig. 2. Number of compounds exhibiting highest recovery at varying: temperature (a), extra
ionisation modes.majority of micropollutants (52 of 81) (Fig. 2). This temperature is
lower than previously developed MAE methods for other envi-
ronmental matrices (sludge, sediments and soils) [21e23,25,26].
Poorer recovery at 70 C was attributed to increased matrix75/25 50/50 25/75 0.5 1 2
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studied micropollutants from P. australis using optimised microwave assisted extrac-
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Fig. 4. Matrix suppression of studied micropollutants in P. australis extracts (ordered
by micropollutant class e see Table 1). Key: E1, estrone; E2, 17b-estradiol; EE2, 17a-
ethinylestradiol; CBZ, carbamazepine; EDDP, 2-ethylidene-1,5-dimethyl-3,3-
diphenylpyrrolidine; MDMA, 3,4-methylenedioxy-methamphetamine; MDA, 3,4-
methylenedioxy-amphetamine; AEME, anhydroecgonine methylester; MDPV,
methylenedioxypyrovalerone.
B. Petrie et al. / Analytica Chimica Acta 959 (2017) 91e10196suppression of analyte signal strength (over lower extraction re-
covery) caused by increasingly heterogeneous extracts as temper-
ature was increased. This could be overcome by using more
selective SPE sorbents. However, this would require more than one
SPE protocol to encompass the range of micropollutants studied
here. Micropollutants which are not thermally stable may also
degrade at higher extraction temperatures [16]. Nevertheless,
simultaneous extraction and satisfactory recovery of all micro-
pollutants was achieved using the non-selective HLB sorbent at an
extraction temperature of 50 C.
In contrast to temperature, the solvent compositions tested for
extraction had less impact to micropollutant recovery (Fig. 2). A
solvent mixture containing MeOH:H2O (and in some cases buffers/
salts added) is a popular choice for extraction [21e23], and is easily
made compatiblewith the SPEmethod applied. Other solvents such
as hexane can be used, but it is considered to enhance the extrac-
tion of hydrophobic constituents which can increase matrix
Table 2
Method detection and quantitation limits of studied micropollutants in P. australis
(n ¼ 81, ordered by micropollutant class).
Micropollutant class Micropollutant MDL
(ng g1 dry
weight)
MQL
(ng g1 dry
weight)
UV ﬁlters Benzophenone-1 0.13 0.78
Benzophenone-2 0.21 1.06
Benzophenone-3 0.20 1.01
Benzophenone-4 1.76 5.74
Parabens Methylparaben 0.08 0.49
Ethylparaben 0.21 0.77
Propylparaben 0.24 0.72
Butylparaben 0.06 0.34
Plasticizer Bisphenol-A 0.39 1.30
Steroid estrogens E1 1.89 9.27
E2 1.69 8.85
EE2 2.68 12.88
Antibacterials/
antibiotics
Sulfasalazine 3.17 10.57
Clarithromycin 0.06 0.35
Azithromycin 0.45 1.67
Trimethoprim 0.11 0.37
Sulfamethoxazole 0.14 0.45
Hypertension Valsartan 2.76 9.08
Irbesartan 1.43 7.15
NSAIDs Ketoprofen 0.69 3.37
Ibuprofen 0.02 0.12
Naproxen 0.51 2.49
Diclofenac 0.12 0.40
Acetaminophen 3.01 14.79
Lipid regulators Bezaﬁbrate 0.12 0.39
Atorvastatin 0.04 0.19
Diabetes Gliclazide 0.06 0.30
Antihistamines Fexofenadine 0.58 1.75
Cetirizine 0.10 0.41
Cough suppressant Pholcodine 4.94 16.08
Beta-blocker Atenolol 0.25 0.82
Metoprolol 0.03 0.13
Propranolol 0.30 0.89
H2 receptor agonists Ranitidine 4.71 23.64
Cimetidine 0.29 1.49
X-ray contrast
media
Iopromide 7.14 35.62
Drug precursor and
metabolite
Ephedrine/
pseudoephedrine
0.38 1.27
Norephedrinea 0.20 10.10
Anti-cancer Azathioprine 0.13 0.43
Methotrexate 9.84 32.33
Ifosfamide 0.04 0.20
Anaesthetic and
metabolite
Ketamine 0.04 0.18
Norketaminea 0.10 0.34
Anti-depressants
and metabolites
Venlafaxine 0.05 0.18
Desmethylvenlafaxinea 0.09 0.29
Mirtazapine 0.11 0.55
Citalopram 0.60 6.02
Desmethylcitaloprama 0.15 0.76
Anti-epileptic and
metabolites
CBZ 0.06 0.30
CBZ 10,11-epoxidea 0.11 0.38
10,11-Dihydro-10-
hydroxy CBZa
0.15 1.54
Human indicators Nicotine 0.86 2.85
Caffeine 0.78 3.88
Cotininea 0.06 0.32
Calcium channel
blocker
Diltiazem 0.12 1.21
Hypnotic Temazepam 0.07 0.34
Anti-psychotic Quetiapine 0.17 0.83
Veterinary Tylosin 0.68 3.44
Analgaesics and
metabolites
Morphine 3.02 10.06
Dihydromorphinea 0.33 1.65
Normorphinea 12.71 42.38
Methadone 0.11 0.57
EDDPa 0.10 0.48
Codeine 0.22 1.11
Norcodeinea 1.01 3.37
Dihydrocodeinea 0.08 0.26
Tramadol 0.03 3.07
N-desmethyltramadola 0.04 2.09
Table 2 (continued )
Micropollutant class Micropollutant MDL
(ng g1 dry
weight)
MQL
(ng g1 dry
weight)
O-desmethyltramadola 0.02 2.36
Stimulants and
metabolites
Amphetamine 0.21 0.70
Methamphetamine 0.15 0.51
MDMA 0.04 0.19
MDAa 0.10 0.33
Cocaine 0.04 0.20
Benzoylecgoninea 0.04 0.22
AEMEa 2.72 13.61
Cocaethylenea 0.05 0.25
Mephedrone 0.06 0.30
MDPV 0.06 0.30
Opioid and
metabolite
Heroin 0.45 2.25
6-acetylmorphinea 0.07 0.23
Key: MDL, method detection limit; MQL, method quantitation limit; E1, estrone; E2,
17b-estradiol; EE2, 17a-ethinylestradiol; CBZ, carbamazepine; EDDP, 2-ethylidene-
1,5-dimethyl-3,3-diphenylpyrrolidine; MDMA, 3,4-methylenedioxy-methamphet-
amine; MDA, 3,4-methylenedioxy-amphetamine; AEME, anhydroecgonine meth-
ylester; MDPV, methylenedioxypyrovalerone.
a Metabolite.
B. Petrie et al. / Analytica Chimica Acta 959 (2017) 91e101 97suppression considerably [18]. The MeOH:H2O ratios trialled were
25:75, 50:50 and 75:25. Using 25 mL of 25:75 MeOH:H2O gave the
highest recovery for the highest number of compounds (Fig. 2).
Although the gains were marginal (few percent), it was also ad-
vantageous to use 25:75 MeOH: H2O for sample processing as a
lower volume of H2O was required for dilution prior to SPE. This
kept the analysis time required for SPE to a minimum.
When developing an extraction method for environmental
matrices, it is essential to determine the greatest sample volume or
mass which yields maximum recovery. This ensures maximum
sensitivity of the method can be achieved. Of the three masses
tested (0.5, 1.0 and 2.0 g), a sample mass of 0.5 g gave the highest
recovery. This is similar to previously reported MAE methods
developed for environmental matrices (Fig. 2) [21,23,26]. Poorer
recovery was observed at sample masses of 1.0 and 2.0 g which is
likely to be caused by increased matrix suppression and/or satu-
ration of the HLB sorbent due to higher quantities of co-extractives.
It can be expected that some improvement in recovery will be
achieved at lower sample masses. However, 0.5 g ensured adequate
sensitivity (with the recovery achieved) for the low ng g1 con-
centrations of micropollutants anticipated to be found in P. australis
here. Throughout the development process, no difference in trend
was observed between micropollutants determined in ESI - or
ESI þ modes for the extraction variables studied (Fig. 2).3.3. Method validation
To validate the method, micropollutant recovery was deter-
mined by spiking samples in triplicate at 25, 50 and 125 ng g1.
Absolute recoveries (i.e., not accounting for the internal standard
response) of the 81 studied micropollutants ranged from 2.4% to
45.1% (Fig. 3). Selection of internal standards for micropollutants
which did not have their own deuterated or C13 analogues avail-
able was based on structural similarity and chromatographic
retention time to best account for matrix suppression. Corrected
recovery/method accuracy (i.e., analyte losses accounted for using
internal standards) ranged from 15% for normorphine to 174% for
10,11-dihydro-10-hydroxycarbamazepine, with the majority of
compounds exhibited corrected recoveries in the range 80e120%
(Fig. 3, Table S5). This range of recoveries is typical formulti-residue
methods investigating a high number of micropollutants (>50) in
environmental matrices [23,27,28]. The overall precision of the
B. Petrie et al. / Analytica Chimica Acta 959 (2017) 91e10198method was generally within ±20% (Fig. 3, Table S6).
Matrix suppression (%) of analyte signal strength was quantiﬁed
by comparing extracted samples spiked post SPE and non-spiked
samples with the standard solution used for spiking:
MS ¼ PA spiked ex PA ex
PA std
x 100 (1)
Where PA spiked ex is the peak area of the spiked extract post
SPE, PA ex is the peak area of the extract (not spiked) and PA std is
the peak area of the standard solution used for spiking. Therefore
suppression of 0% shows no matrix suppression and complete
suppression would be 100%. All compounds were subject to sup-
pressionwhich ranged from 10% to 93% (Fig. 4, Table S7). In general,
lower signal suppression was observed for micropollutants deter-
mined in ESI - mode. These levels of signal suppression are typical
of previously reported multi-residue methods investigating
micropollutants in other solid environmental matrices [22,23,29].
Again, this was a result of extracting environmental matrices using
the non-selective HLB sorbent. Nevertheless it was essential for the
simultaneous extraction of the broad range of micropollutants
studied. This also demonstrates that the use of labelled internal
standards to correct for matrix suppression as well as analyte lossesK
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Fig. 5. UHPLC-MS/MS chromatograms of micropollutants found in P. australis (sample ree
micropollutants in spiked P. australis see Fig. S1. Key: CBZ, carbamazepine; EDD
methamphetamine.during sample preparation was essential.
To determine the method's sensitivity, method detection limits
(MDLs, ng g1) and MQLs (ng g1) were calculated according to
[22]:
MDL ¼ S x IDL x 100
Abs Rec x CF
(2)
MQL ¼ S x IQL x 100
Abs Rec x CF
(3)
S is the volume of solvent used for extraction (mL) divided by
the mass of sample (g). IDL and IQL are the instrument detection
and quantitation limits, respectively (ng mL1). Abs Rec is the ab-
solute recovery of themethod (%) and CF is the concentration factor.
MDLs were <1 ng g1 for 65 of the 81 micropollutants studied,
demonstrating the sensitivity of the method developed (Table 2).
The corresponding MQLs ranged from 0.2 to 42.4 ng g1 with the
majority of compounds being <5 ng g1. These MQLs are similar to
other MAE methods used to extract organic micropollutants from
digested sludge [22,23,26,30] and sediments [25,26]. From the very
limited data available on the level of micropollutants in macro-
phytes used to treat municipal wastewater [19,20], the reportedVe
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B. Petrie et al. / Analytica Chimica Acta 959 (2017) 91e101 99MQLs are adequately sensitive for their determination at concen-
trations expected to be found in the ﬁeld.
3.4. Method application
The developed method was applied to determine the concen-
tration of micropollutants in P. australis from a constructed wetland
treating secondary municipal (trickling ﬁlter) efﬂuent in the UK. A
total of eight plants were collected over four consecutive days. Of
the 81 micropollutants investigated, 17 were found above their
respective MQL at least once (Fig. 5). These compounds were
methylparaben, bisphenol-A, propranolol, ketamine, venlafaxine,
mirtazapine, carbamazepine, diltiazem, caffeine, methadone, tra-
madol and MDMA, as well as the metabolites norketamine,0
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Fig. 6. Concentration of micropollutants found in P. australis collected from constructed
quantitation limit; CBZ, carbamazepine; EDDP, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrdesvenlafaxine, carbamazepine 10,11 epoxide, EDDP and N-des-
methyltramadol. Such micropollutants are commonly found in
trickling ﬁlter efﬂuents in the UK [2].
Mean concentrations (n ¼ 8 plants) of the 17 detected micro-
pollutants ranged from<5 ng g1 for desvenlafaxine, diltiazem, and
EDDP to 197 ± 84 ng g1 for methylparaben (Fig. 6). There was no
apparent difference in micropollutant concentration from
P. australis collected close to the inlet and outlet of the constructed
wetland. There is a paucity of information on the concentration of
micropollutants found in emergent macrophytes such as P. australis
used to treated municipal wastewater. Hijosa-Valsero et al. [20]
measured the concentration of the pharmaceuticals ibuprofen,
naproxen and salicylic acid in the roots of P. australis. Concentra-
tions in roots ranged from 100 to 2500 ng g1 fresh weight. TheKetamine Norketamine Venlafaxine
CBZ 10,11 epoxide Diltiazem Caffeine
N-desmethyltramadol MDMA
Reed 1 (day 1 outlet)
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wetland treating secondary (trickling ﬁlter) efﬂuent (Table S8). Key: MQL, method
olidine; MDMA, 3,4-methylenedioxy-methamphetamine.
B. Petrie et al. / Analytica Chimica Acta 959 (2017) 91e101100comparatively higher concentrations in their study is attributed to
the likelihood that these compounds were present in the receiving
wastewater for treatment at greater concentrations. The receiving
wastewater was settled sewage (post primary treatment) whereas
our study treated secondary efﬂuent (post trickling ﬁlter treat-
ment). However, within plant variations in concentration may also
contribute to this difference as in our study the whole plant was
investigated (roots, stem and leaves). Future application of the
method will address this issue by investigating micropollutant
concentrations throughout the various sections of the plant.
Furthermore, several of the detected micropollutants are chiral in
nature. It is postulated that enantiomers of the same chiral com-
pounds will be taken up, transported and metabolised within
P. australis at different rates. The pesticide isofenphos-methyl has
been found to bemetabolised stereoselectively in the vegetable pak
choi [31].
Interestingly, several of the micropollutants found in P. australis
such as carbamazepine and ketamine are poorly removed by con-
ventional secondary wastewater treatment processes such as
trickling ﬁlters and activated sludge [2]. Their presence in
P. australis indicates uptake is a viable removal pathway for these
normally recalcitrant compounds. Furthermore, the occurrence of
their metabolites carbamazepine 10,11 epoxide and norketamine
suggests that metabolism of the parent micropollutant may also
occur within the plant. The determination of metabolites has been
previously used to suggest that metabolism of carbamazepine
within plants such as vegetables [32,33] and other macrophytes
(Cattail) [34] takes place. Depending on their rate of uptake and
metabolism by P. australis, constructed wetlands could be suc-
cessful for the removal of these normally recalcitrant micro-
pollutants from wastewater. The focus of future work will be to
establish a complete process mass balance of the constructed
wetland for all micropollutants. This will enable the performance of
the constructed wetland for micropollutant removal to be assessed
whilst determining the dominant mechanisms of removal for each
individual compound.
4. Conclusion
A new multi-residue method was developed and validated for
the determination of 81 organic micropollutants including me-
tabolites in the emergent macrophyte P. australis. The use of MAE,
off-line SPE and UHPLC-MS/MS achieved MQLs <5 ng g1 for the
majority of studied compounds. Application of the method found
17 micropollutants at concentrations up to 200 ng g1 in P. australis
collected from constructed wetlands treating municipal waste-
water. Other than uptake, the determination of several metabolites
indicates plant metabolism may occur. This method will be used to
further investigate the role of phytoremediation in the removal of
micropollutants by constructed wetlands.
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